Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 2 , Pages 209-221 , June 2007

Cellular entry of thyroid hormones by organic anion transporting polypeptides

  • Bruno Hagenbuch (Professor of Pharmacology and Member of the University of Kansas Cancer Center)

      Affiliations

    • Corresponding Author InformationTel.: +1 913 588 0028; Fax: +1 913 588 7501.

References 

  1. Stitzer LK, Jacquez JA. Neutral amino acid transport pathways in uptake of L-thyroxine by Ehrlich ascites cells. The American Journal of Physiology. 1975;229:172–177
  2. Rao GS, Eckel J, Rao ML, et al. Uptake of thyroid hormone by isolated rat liver cells. Biochemical and Biophysical Research Communications. 1976;73:98–104
  3. Krenning EP, Docter R, Bernard HF, et al. Active transport of triiodothyronine (T3) into isolated rat liver cells. FEBS Letters. 1978;91:113–116
  4. Friesema EC, Docter R, Moerings EP, et al. Identification of thyroid hormone transporters. Biochemical and Biophysical Research Communications. 1999;254:497–501
  5. Hagenbuch B, Meier PJ. Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Archive. 2004;447:653–665
  6. Hagenbuch B, Meier PJ. The superfamily of organic anion transporting polypeptides. Biochimica et Biophysica Acta. 2003;1609:1–18
  7. Konig J, Seithel A, Gradhand U, et al. Pharmacogenomics of human OATP transporters. Naunyn-Schmiedeberg's Archives of Pharmacology. 2006;372:432–443
  8. Gao B, Hagenbuch B, Kullak-Ublick GA, et al. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. The Journal of Pharmacology and Experimental Therapeutics. 2000;294:73–79
  9. Bronger H, Konig J, Kopplow K, et al. ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Research. 2005;65:11419–11428
  10. Lee W, Glaeser H, Smith LH, et al. Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry. The Journal of Biological Chemistry. 2005;280:9610–9617
  11. Sugiyama D, Kusuhara H, Taniguchi H, et al. Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. The Journal of Biological Chemistry. 2003;278:43489–43495
  12. Tohyama K, Kusuhara H, Sugiyama Y. Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology. 2004;145:4384–4391
  13. Huber RD, Gao B, Sidler Pfaendler MA, et al. Characterization of two splice variants of human organic anion transporting polypeptide 3a1 (Oatp3a1) isolated from human brain. American Journal of Physiology. 2007;292:C795–C806
  14. Gao B, Huber RD, Wenzel A, et al. Localization of organic anion transporting polypeptides in the rat and human ciliary body epithelium. Experimental Eye Research. 2005;80:61–72
  15. Kobayashi D, Nozawa T, Imai K, et al. Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. The Journal of Pharmacology and Experimental Therapeutics. 2003;306:703–708
  16. Grube M, Kock K, Oswald S, et al. Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart. Clinical Pharmacology and Therapeutics. 2006;80:607–620
  17. Mikkaichi T, Suzuki T, Onogawa T, et al. Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:3569–3574
  18. König J, Cui Y, Nies AT, et al. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. The Journal of Biological Chemistry. 2000;275:23161–23168
  19. Abe T, Unno M, Onogawa T, et al. LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001;120:1689–1699
  20. Kullak-Ublick GA, Ismair MG, Stieger B, et al. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001;120:525–533
  21. Pizzagalli F, Varga Z, Huber RD, et al. Identification of steroid sulfate transport processes in the human mammary gland. The Journal of Clinical Endocrinology and Metabolism. 2003;88:3902–3912
  22. St-Pierre MV, Ugele B, Hagenbuch B, et al. Characterization of an organic anion transporting polypeptide (OATP-B) in human placenta. The Journal of Clinical Endocrinology and Metabolism. 2002;87:1856–1863
  23. Sato K, Sugawara J, Sato T, et al. Expression of organic anion transporting polypeptide E (OATP-E) in human placenta. Placenta. 2003;24:144–148
  24. Pizzagalli F, Hagenbuch B, Stieger B, et al. Identification of a novel human organic anion transporting polypeptide (OATP-F) as a high affinity thyroxine transporter. Molecular Endocrinology (Baltimore, Md.). 2002;16:2283–2296
  25. Jacquemin E, Hagenbuch B, Stieger B, et al. Expression cloning of a rat liver Na+-independent organic anion transporter. Proceedings of the National Academy of Sciences of the United States of America. 1994;91:133–137
  26. Meier PJ, Eckhardt U, Schroeder A, et al. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology. 1997;26:1667–1677
  27. Kanai N, Lu R, Bao Y, et al. Estradiol 17 beta-D-glucuronide is a high-affinity substrate for oatp organic anion transporter. The American Journal of Physiology. 1996;270:F326–F331
  28. Bossuyt X, Muller M, Hagenbuch B, et al. Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver. The Journal of Pharmacology and Experimental Therapeutics. 1996;276:891–896
  29. Ismair MG, Stieger B, Cattori V, et al. Hepatic uptake of cholecystikinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver. Gastroenterology. 2001;121:1185–1190
  30. Yarim M, Moro S, Huber R, et al. Application of QSAR analysis to organic anion transporting polypeptide 1a5 (Oatp1a5) substrates. Bioorganic & Medicinal Chemistry. 2005;13:463–471
  31. Chang C, Pang KS, Swaan PW, et al. Comparative pharmacophore modeling of organic anion transporting polypeptides: a meta-analysis of rat Oatp1a1 and human OATP1B1. The Journal of Pharmacology and Experimental Therapeutics. 2005;314:533–541
  32. Kullak-Ublick GA, Hagenbuch B, Stieger B, et al. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology. 1995;109:1274–1282
  33. Kullak-Ublick GA, Glasa J, Boker C, et al. Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas. Gastroenterology. 1997;113:1295–1305
  34. Fujiwara K, Adachi H, Nishio T, et al. Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology. 2001;142:2005–2012
  35. Abe T, Kakyo M, Tokui T, et al. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. The Journal of Biological Chemistry. 1999;274:17159–17163
  36. Hsiang B, Zhu Y, Wang Z, et al. A novel human hepatic organic anion transporting polypeptide (OATP2). The Journal of Biological Chemistry. 1999;274:37161–37168
  37. König J, Cui Y, Nies AT, et al. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. The American Journal of Physiology. 2000;278:G156–G164
  38. Tamai I, Nezu J, Uchino H, et al. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochemical and Biophysical Research Communications. 2000;273:251–260
  39. Schuster VL. Molecular mechanisms of prostaglandin transport. Annual Review of Physiology. 1998;60:221–242
  40. Cui Y, König J, Leier I, et al. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. The Journal of Biological Chemistry. 2001;276:9626–9630
  41. Briz O, Serrano MA, Rebollo N, et al. Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells. Molecular Pharmacology. 2002;61:853–860
  42. Meier-Abt F, Faulstich H, Hagenbuch B. Identification of phalloidin uptake systems of rat and human liver. Biochimica et Biophysica Acta. 2004;1664:64–69
  43. Maeda K, Kambara M, Tian Y, et al. Uptake of ursodeoxycholate and its conjugates by human hepatocytes: role of Na(+)-taurocholate cotransporting polypeptide (NTCP), organic anion transporting polypeptide (OATP) 1B1 (OATP-C), and oatp1B3 (OATP8). Molecular Pharmaceutics. 2006;3:70–77
  44. Fischer WJ, Altheimer S, Cattori V, et al. Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin. Toxicology and Applied Pharmacology. 2005;203:257–263
  45. Nakagomi-Hagihara R, Nakai D, Kawai K, et al. OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker. Drug Metabolism and Disposition: The Biological Fate of Chemicals. 2006;34:862–869
  46. Fehrenbach T, Cui Y, Faulstich H, et al. Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins. Naunyn-Schmiedeberg's Archives of Pharmacology. 2003;368:415–420
  47. Hirano M, Maeda K, Shitara Y, et al. Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans. The Journal of Pharmacology and Experimental Therapeutics. 2004;311:139–146
  48. Vavricka SR, van Montfoort J, Ha HR, et al. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology. 2002;36:164–172
  49. Tirona RG, Leake BF, Wolkoff AW, et al. Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. The Journal of Pharmacology and Experimental Therapeutics. 2003;304:223–228
  50. Ho RH, Tirona RG, Leake BF, et al. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology. 2006;130:1793–1806
  51. Tsuda-Tsukimoto M, Maeda T, Iwanaga T, et al. Characterization of hepatobiliary transport systems of a novel alpha4beta1/alpha4beta7 dual antagonist, TR-14035. Pharmaceutical Research. 2006;23:2646–2656
  52. Yamashiro W, Maeda K, Hirouchi M, et al. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans. Drug metabolism and Disposition: The Biological Fate of Chemicals. 2006;34:1247–1254
  53. Takeuchi A, Masuda S, Saito H, et al. Multispecific substrate recognition of kidney-specific organic anion transporters OAT-K1 and OAT-K2. The Journal of Pharmacology and Experimental Therapeutics. 2001;299:261–267
  54. Abe T, Kakyo M, Sakagami H, et al. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. The Journal of Biological Chemistry. 1998;273:22395–22401
  55. Cattori V, Hagenbuch B, Hagenbuch N, et al. Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liver-specific transporter-1 (rlst-1) in rat liver. FEBS Letters. 2000;474:242–245
  56. Suzuki T, Onogawa T, Asano N, et al. Identification and characterization of novel rat and human gonad specific organic anion transporters. Molecular Endocrinology (Baltimore, Md.). 2003;3:3

PII: S1521-690X(07)00025-5

doi: 10.1016/j.beem.2007.03.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 2 , Pages 209-221 , June 2007

Article Tools

* Image Usage & Resolution